[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fzSF0hTLXqJWdufVDHCJWJCGUtflswQ0qSIUYAQBsA7g":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":38,"rows":45},"Nigde Omer Halisdemir University",[4],78,false,25,0,7965,1,74,[14,17,19,21,23,25,27,30],{"name":15,"count":16},"Healthy Young Adults",3,{"name":18,"count":16},"Multiple Sclerosis",{"name":20,"count":16},"Postoperative Pain",{"name":22,"count":16},"Sleep",{"name":24,"count":16},"Breastfeeding",{"name":26,"count":16},"Pain",{"name":28,"count":29},"Idiopathic Parkinson's Disease",2,{"name":31,"count":29},"Fatigue",[33],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT07328698","Postoperative Ozonated Oil Dressing After Open Inguinal Hernia Repair: A Randomized Pilot Trial","2026-04-30","ozonated oil",[39,40,41,42,43,44],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[46,70,99,117,145,163],{"intervention":37,"totalTrials":11,"cells":47},{"EARLY_PHASE1":48,"PHASE1":50,"PHASE2":52,"PHASE3":54,"PHASE4":56,"NA":58},{"trials":49,"activeCount":9},[],{"trials":51,"activeCount":9},[],{"trials":53,"activeCount":9},[],{"trials":55,"activeCount":9},[],{"trials":57,"activeCount":9},[],{"trials":59,"activeCount":11,"soonestReadout":36},[60],{"nctId":34,"briefTitle":35,"status":61,"phases":62,"primaryCompletion":36,"completion":63,"start":64,"enrollment":65,"conditions":66,"interventions":69},"RECRUITING",[44],"2026-05-31","2026-02-10",60,[67,68],"Inguinal Hernia Unilateral","Postoperative Wound Inflammation",[37],{"intervention":71,"totalTrials":11,"cells":72},"Diprospan",{"EARLY_PHASE1":73,"PHASE1":75,"PHASE2":77,"PHASE3":79,"PHASE4":81,"NA":97},{"trials":74,"activeCount":9},[],{"trials":76,"activeCount":9},[],{"trials":78,"activeCount":9},[],{"trials":80,"activeCount":9},[],{"trials":82,"activeCount":9},[83],{"nctId":84,"briefTitle":85,"status":86,"phases":87,"primaryCompletion":88,"completion":89,"start":90,"enrollment":91,"conditions":92,"interventions":95},"NCT07242846","EFFECT OF INTRAARTICULAR TRIAMCINOLONE HEXACETONIDE AND BETAMETHASONE ON INTRAOCULAR PRESSURE","COMPLETED",[43],"2025-11-02","2025-11-10","2025-10-02",80,[93,94],"Knee Osteoarthritis (Knee OA)","Intraocular Pressure",[71,96],"artropan",{"trials":98,"activeCount":9},[],{"intervention":96,"totalTrials":11,"cells":100},{"EARLY_PHASE1":101,"PHASE1":103,"PHASE2":105,"PHASE3":107,"PHASE4":109,"NA":115},{"trials":102,"activeCount":9},[],{"trials":104,"activeCount":9},[],{"trials":106,"activeCount":9},[],{"trials":108,"activeCount":9},[],{"trials":110,"activeCount":9},[111],{"nctId":84,"briefTitle":85,"status":86,"phases":112,"primaryCompletion":88,"completion":89,"start":90,"enrollment":91,"conditions":113,"interventions":114},[43],[93,94],[71,96],{"trials":116,"activeCount":9},[],{"intervention":118,"totalTrials":11,"cells":119},"25 mcg fentanyl",{"EARLY_PHASE1":120,"PHASE1":122,"PHASE2":124,"PHASE3":126,"PHASE4":128,"NA":130},{"trials":121,"activeCount":9},[],{"trials":123,"activeCount":9},[],{"trials":125,"activeCount":9},[],{"trials":127,"activeCount":9},[],{"trials":129,"activeCount":9},[],{"trials":131,"activeCount":9},[132],{"nctId":133,"briefTitle":134,"status":86,"phases":135,"primaryCompletion":136,"completion":137,"start":138,"enrollment":139,"conditions":140,"interventions":143},"NCT04196946","Use of Intrathecal Analgesia in Appendectomy",[44],"2015-09-02","2019-09-02","2013-09-02",50,[141,142],"Anesthesia","Analgesia",[118,144],"250 mcg alfentanil",{"intervention":144,"totalTrials":11,"cells":146},{"EARLY_PHASE1":147,"PHASE1":149,"PHASE2":151,"PHASE3":153,"PHASE4":155,"NA":157},{"trials":148,"activeCount":9},[],{"trials":150,"activeCount":9},[],{"trials":152,"activeCount":9},[],{"trials":154,"activeCount":9},[],{"trials":156,"activeCount":9},[],{"trials":158,"activeCount":9},[159],{"nctId":133,"briefTitle":134,"status":86,"phases":160,"primaryCompletion":136,"completion":137,"start":138,"enrollment":139,"conditions":161,"interventions":162},[44],[141,142],[118,144],{"intervention":164,"totalTrials":11,"cells":165},"Denosumab 60 MG\u002FML",{"EARLY_PHASE1":166,"PHASE1":168,"PHASE2":170,"PHASE3":172,"PHASE4":174,"NA":176},{"trials":167,"activeCount":9},[],{"trials":169,"activeCount":9},[],{"trials":171,"activeCount":9},[],{"trials":173,"activeCount":9},[],{"trials":175,"activeCount":9},[],{"trials":177,"activeCount":9},[178],{"nctId":179,"briefTitle":180,"status":86,"phases":181,"primaryCompletion":182,"completion":182,"start":183,"enrollment":184,"conditions":185,"interventions":187},"NCT04702204","Efficacy of Denosumab Treatment in Bisphosphonate Unresponsive Patients",[],"2021-08-15","2020-07-01",73,[186],"Postmenopausal Osteoporosis",[164]]